Similarly, Bolshakov et al. found p53 in the majority (66%) of aggressive BCCs [86]; overall, increased p53 expression has been associated with tumor aggressiveness [87], reinforcing the notion that morBCC is an aggressive subtype. This evidence concerns the gene TP53 and neoplasm.